List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 197 studies with search of: intersex
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE.
Condition: LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE UCNT
Intervention: Drug: Hydroxyurea
2 Recruiting Induction Therapy-Docetaxel, Cisplatin and Fluorouracil in Untreated Advanced Squamous Cell or Undifferentiated Carcinoma of the Paranasal Sinuses
Conditions: Paranasal Sinuses;   Squamous Cell Carcinoma
Interventions: Drug: Docetaxel;   Drug: 5-Fluorouracil;   Drug: Cisplatin
3 Enrolling by invitation Oxygen Therapy for the Treatment of Undifferentiated Headache in the Emergency Department
Condition: Headache
Interventions: Biological: Medical Air;   Biological: Oxygen
4 Completed NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)
Condition: Head and Neck Neoplasms
Intervention: Drug: DOCETAXEL(XRP6976)
5 Recruiting Studies of the Natural History and Pathogenesis and Outcome of Neonatal Onset Multisystem Inflammatory Disease (NOMID/CAPS, DIRA, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases)
Conditions: Urticaria;   Arthropathy;   Lymphadenopathy;   Nervous System Anomalies
Intervention:
6 Active, not recruiting Phase II Study of AZD2281 in Known BRCA or Recurrent High Grade Ovarian Cancer or Known BRCA/ Triple Neg Breast Cancer
Conditions: Ovarian Carcinoma;   Breast Cancer
Intervention: Drug: AZD2281
7 Completed
Has Results 		Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients
Condition: Arthritis, Rheumatoid
Interventions: Drug: Abatacept;   Drug: placebo
8 Completed Qualitative Research on Women With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Other: Interview
9 Recruiting Measuring Temperatures of Tissues During Endoscopy
Condition: Carcinoma, Undifferentiated
Intervention: Other: no intervention
10 Not yet recruiting Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy
Conditions: Psoriatic Arthritis;   Ankylosing Spondylitis;   Undifferentiated Spondyloarthropathy
Intervention:
11 Recruiting Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck;   Basaloid Squamous Cell Carcinoma;   Undifferentiated Carcinoma;   Adenosquamous Cell Carcinoma
Interventions: Drug: Abraxane;   Drug: Erbitux;   Drug: Carboplatin;   Radiation: Intensity Modulated Radiation Therapy
12 Recruiting Panitumumab Plus Chemoradiotherapy and Induction Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck;   Basaloid Squamous Cell Carcinoma;   Undifferentiated Carcinoma;   Adenosquamous Cell Carcinoma
Interventions: Drug: Panitumumab;   Drug: Carboplatin;   Drug: Paclitaxel;   Radiation: Intensity Modulated Radiation Therapy;   Drug: 5-Fluorouracil;   Drug: Docetaxel;   Drug: Cisplatin
13 Recruiting Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute Graft Versus Host Disease (aGVHD) During Transplant
Conditions: AML;   ALL;   Undifferentiated Leukemia;   Biphenotypic Leukemia;   Refractory Anemia;   Refractory Anemia With Ringed Sideroblasts;   Refractory Cytopenia With Multilineage Dysplasia;   Refractory Cytopenia With Multilineage Dysplasia and Ringed Sideroblasts;   Refractory Anemia With Excess Blasts-1 (5-10% Blasts);   Refractory Anemia With Excess Blasts-2 (10-20% Blasts);   Myelodysplastic Syndrome, Unclassified;   MDS Associated With Isolated Del (5q)
Intervention: Drug: Abatacept
14 Completed Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT)
Conditions: Asthma;   Chronic Obstructive Pulmonary Disease (COPD);   Undifferentiated Asthma/COPD
Intervention: Device: High Frequency Chest Wall Oscillator
15 Recruiting Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Acute Undifferentiated Leukemia;   Biphenotypic Leukemia;   Myelodysplastic Syndrome;   Non-Hodgkin's Lymphoma
Interventions: Procedure: MRI and cognitive evaluation;   Procedure: brain MRI study and a brief neuropsychological evaluation
16 Active, not recruiting Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
Conditions: Drug/Agent Toxicity by Tissue/Organ;   Head and Neck Cancer;   Oral Complications;   Radiation Toxicity
Interventions: Drug: amifostine trihydrate;   Drug: carboplatin;   Drug: cisplatin;   Drug: paclitaxel;   Radiation: radiation therapy
17 Completed Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Biological: filgrastim;   Biological: sargramostim;   Drug: cyclophosphamide;   Drug: vincristine sulfate;   Radiation: radiation therapy
18 Active, not recruiting Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
Condition: Lung Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
19 Not yet recruiting Paclitaxel/Carboplatin With or Without Cetuximab in CUP
Conditions: Neoplasms, Unknown Primary;   Carcinoma
Interventions: Drug: paclitaxel/carboplatin;   Drug: cetuximab
20 Recruiting Evaluation of Efficacy and Safety of Long-Acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
Conditions: Schizophrenia, Catatonic;   Schizophrenia, Disorganized;   Schizophrenia, Paranoid;   Schizophrenia;   Psychotic Disorders
Intervention: Drug: Long-acting Risperidone microspheres injection

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services